Update to living WHO guideline on drugs for covid-19

Update provides conditional recommendation for remdesivir in severe Covid-19 and against use in critical disease; strong recommendation against use of sotrovimab and casirivimab-imdevimab; IL-6 receptor blockers and baricitinib can now be combined in critical/severe disease.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: COVID-19 | Health